BCAX

Bicara Therapeutics Inc.

Healthcare · Biotechnology

$192.88 sample

-2.87 (-1.47%) 1D

Market cap

$209.7B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-11

Alerts

8

Price$192.88 +7.65% 3M daily closessample

212.18178.62

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Chief Executive Officer
Sep 22INSInsider buy: Director
Sep 11SEC8-K filed: material event
Sep 08INSInsider buy: Chief Financial Officer
Aug 31INSInsider buy: EVP, Operations
Aug 21INSInsider buy: Director
Aug 12SEC10-Q filed
Aug 06INSInsider sell: 10% owner

Sign up to see the real BCAX record →

Company facts

SEC EDGAR registration

Name: Bicara Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -11sample, -100 to +100
Reporting currency: USD

Who is positioning in BCAX

sample

Insiders: 23 insider transactions over 90 days, net selling, $136.5M
Congress: 3 members traded over 90 days
Institutions · 13F: 16 funds hold $3.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.9B +12.3% y/y

Q4 2024Q3 2026

Inventory$3.0B +13.5% y/y

Q4 2024Q3 2026

Accounts receivable$2.2B +18.2% y/y

Q4 2024Q3 2026

Total debt$5.8B +14.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $143.8B -12.7% 3M
Sample peer B: $51.5B -4.5% 3M
Sample peer C: $117.9B +9.1% 3M
Sample peer D: $179.6B -9.0% 3M
Sample peer E: $196.8B +13.8% 3M